Follow
Lovro Ziberna
Lovro Ziberna
Institute of Pharmacology, Faculty of Medicine, University of Ljubljana
Verified email at mf.uni-lj.si
Title
Cited by
Cited by
Year
Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics
X Feng, A Sureda, S Jafari, Z Memariani, D Tewari, G Annunziata, ...
Theranostics 9 (7), 1923, 2019
2772019
Bilberry and blueberry anthocyanins act as powerful intracellular antioxidants in mammalian cells
SM Bornsek, L Ziberna, T Polak, A Vanzo, NP Ulrih, V Abram, F Tramer, ...
Food chemistry 134 (4), 1878-1884, 2012
2122012
Bilirubin is an endogenous antioxidant in human vascular endothelial cells
L Ziberna, M Martelanc, M Franko, S Passamonti
Scientific reports 6 (1), 29240, 2016
1472016
Oleanolic acid alters multiple cell signaling pathways: implication in cancer prevention and therapy
L Žiberna, D Šamec, A Mocan, SF Nabavi, A Bishayee, AA Farooqi, ...
International journal of molecular sciences 18 (3), 643, 2017
1222017
Acute cardioprotective and cardiotoxic effects of bilberry anthocyanins in ischemia–reperfusion injury: beyond concentration-dependent antioxidant activity
L Ziberna, M Lunder, S Moze, A Vanzo, F Tramer, S Passamonti, ...
Cardiovascular Toxicology 10, 283-294, 2010
1052010
Determination of cyanidin 3-glucoside in rat brain, liver and kidneys by UPLC/MS-MS and its application to a short-term pharmacokinetic study
S Fornasaro, L Ziberna, M Gasperotti, F Tramer, U Vrhovšek, F Mattivi, ...
Scientific Reports 6 (1), 22815, 2016
882016
Transport and bioactivity of cyanidin 3-glucoside into the vascular endothelium
L Ziberna, F Tramer, S Moze, U Vrhovsek, F Mattivi, S Passamonti
Free radical biology and medicine 52 (9), 1750-1759, 2012
832012
Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome?
Z Jenko-Pražnikar, A Petelin, M Jurdana, L Žiberna
Metabolism 62 (7), 976-985, 2013
682013
The endothelial plasma membrane transporter bilitranslocase mediates rat aortic vasodilation induced by anthocyanins
L Ziberna, M Lunder, F Tramer, G Drevenšek, S Passamonti
Nutrition, metabolism and cardiovascular diseases 23 (1), 68-74, 2013
612013
Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA. Hy 926 cells
AO Ademosun, G Oboh, S Passamonti, F Tramer, L Ziberna, AA Boligon, ...
Food Science and Human Wellness 4 (2), 80-85, 2015
582015
Bioavailability of flavonoids: The role of cell membrane transporters
L Ziberna, S Fornasaro, J Čvorović, F Tramer, S Passamonti
Polyphenols in human health and disease, 489-511, 2014
552014
Direct determination of free bilirubin in serum at sub-nanomolar levels
M Martelanc, L Žiberna, S Passamonti, M Franko
Analytica chimica acta 809, 174-182, 2014
502014
The influence of temperature on rheological properties of blood mixtures with different volume expanders—implications in numerical arterial hemodynamics simulations
A Zupančič Valant, L Žiberna, Y Papaharilaou, A Anayiotos, GC Georgiou
Rheologica acta 50, 389-402, 2011
492011
Application of high-performance liquid chromatography combined with ultra-sensitive thermal lens spectrometric detection for simultaneous biliverdin and bilirubin assessment at …
M Martelanc, L Žiberna, S Passamonti, M Franko
Talanta 154, 92-98, 2016
472016
Bioavailability of flavonoids: the role of cell membrane transporters
J Čvorović, L Ziberna, S Fornasaro, F Tramer, S Passamonti
Polyphenols: Mechanisms of action in human health and disease, 295-320, 2018
362018
Role of endothelial cell membrane transport in red wine polyphenols-induced coronary vasorelaxation: involvement of bilitranslocase
L Ziberna, JH Kim, C Auger, S Passamonti, V Schini-Kerth
Food & function 4 (10), 1452-1456, 2013
332013
Inhibition of metalloproteinase and proteasome activities in colon cancer cells by citrus peel extracts
AO Ademosun, G Oboh, S Passamonti, F Tramer, L Ziberna, AA Boligon, ...
Journal of Basic and Clinical Physiology and Pharmacology 26 (5), 471-477, 2015
322015
Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta
M Lunder, L Žiberna, M Janić, A Jerin, M Skitek, M Šabovič, G Drevenšek
Heart and vessels 28, 246-254, 2013
272013
Using literature-based discovery to explain adverse drug effects
D Hristovski, A Kastrin, D Dinevski, A Burgun, L Žiberna, TC Rindflesch
Journal of medical systems 40, 1-5, 2016
212016
Farmakologija kanabinoidov
I Ferjan, M Kržan, M Lipnik-Štangelj, L Žiberna, L Stanovnik, K Černe
Slovenian Medical Journal 84 (6), 2015
202015
The system can't perform the operation now. Try again later.
Articles 1–20